Advertisement

July 08, 2011

Volume 286Issue 27p23621-24534, e99953-e99954
Open Access
On The Cover: Topical skin treatment with the tumor promoter TPA (12-O-tetradecanolyphorbol-13-acetate) causes epidermal proliferation and dermal infiltration of inflammatory cells. The image shows the skin of a genetically modified mouse lacking thyroid hormone receptors. These animals present reduced hyperplasia and a stronger inflammatory reaction. Fluorescence microscopy of keratin 5 (red), the lymphocyte marker CD45 (green), and nuclei (blue) are shown. For details see the article by Contreras-Jurado et al., pages 24079–24088....
On The Cover: Topical skin treatment with the tumor promoter TPA (12-O-tetradecanolyphorbol-13-acetate) causes epidermal proliferation and dermal infiltration of inflammatory cells. The image shows the skin of a genetically modified mouse lacking thyroid hormone receptors. These animals present reduced hyperplasia and a stronger inflammatory reaction. Fluorescence microscopy of keratin 5 (red), the lymphocyte marker CD45 (green), and nuclei (blue) are shown. For details see the article by Contreras-Jurado et al., pages 24079–24088.

Papers of the Week

Minireviews

Bioenergetics

Cell Biology

Computational Biology

Developmental Biology

DNA and Chromosomes

Enzymology

Gene Regulation

Genomics and Proteomics

Glycobiology and Extracellular Matrices

Immunology

Lipids

Membrane Biology

Metabolism

Microbiology

Molecular Bases of Disease

Molecular Biophysics

Neurobiology

Plant Biology

Protein Structure and Folding

Protein Synthesis and Degradation

Signal Transduction

Additions and Corrections

Advertisement